DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

Cytokinetics, Inc. (NASDAQ: CYTK)

7.38 0.33 (4.68%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTK $7.38 4.68%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.07
Previous Close $7.05
Daily Range $7.03 - $7.45
52-Week Range $3.05 - $13.26
Market Cap $270.2M
P/E Ratio -19.05
Dividend (Yield) $0.00 (0.0%)
Volume 329,175
Average Daily Volume 662,544
Current FY EPS -$0.95

Sector

Healthcare

Industry

Drugs

Cytokinetics, Inc. (CYTK) Description

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer. Website: http://www.cytokinetics.com/

News & Commentary

Biotech 101: Valuing Binary Events

Sarepta Therapeutics, Revance Therapeutics, and Cytokinetics saw big moves recently; MannKind and Orexigen could be next.

Will Cytokinetics (CYTK) Continue to Surge Higher? - Tale of the Tape

Cytokinetics (CYTK) Looks Good: Stock Soars 16.1% - Tale of the Tape

Cytokinetics (CYTK) Is Weak On High Volume Today

Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Cl

Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Clinical Study Update

Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Cl

Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Clinical Study Update

Mid-Day Gainers From New Year's Eve 2014: NephroGenex And Other Biopharma Stocks

Mid-Day Market Update: Meadowbrook Insurance Shares Jump On Acquisition News; Crude Oil Drops Over 2

Mid-Day Market Update: Meadowbrook Insurance Shares Jump On Acquisition News; Crude Oil Drops Over 2%

Cytokinetics (CYTK) Stock Rises Today After Roth Capital Increases Price Target

Kite Pharma Files IND for Non-Hodgkin Lymphoma Drug - Analyst Blog

Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More

See More CYTK News...

CYTK's Top Competitors

CYTK $7.38 (4.68%)
Current stock: CYTK
GILD $105.54 (0.38%)
Current stock: GILD
BIIB $357.63 (1.13%)
Current stock: BIIB
CELG $123.89 (0.15%)
Current stock: CELG